Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer’s prevention
CHICAGO, Nov 25 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and…
